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In 1928 Shwartzman described a new phenomenon of local skin re- 
activity to culture filtrates of various microorganisms.  The reactivity 
was induced by the injection of a  filtrate into the skin of a  rabbit. 
If an intravenous injection of a potent bacterial filtrate was given to 
the same rabbit from 20 to 24 hours later, there appeared an extremely 
severe hemorrhagic necrosis at the site of the previous injection.  The 
factors determining the local skin reactivity were termed skin-prepara- 
tory factors and those responsible for the local injury following intra- 
venous injection were called reacting factors.  In recent  years,  an 
extensive series of studies on the various aspects of this phenomenon 
has been reported by Shwartzman and other workers. 
Gross (1) described briefly an observation concerning inhibition of the Shwartz- 
man phenomenon.  The inhibition was obtained when an intravenous injection 
of a  bacterial filtrate was given to a rabbit shortly after or simultaneously with 
the skin-preparatory injection.  No reactions followed the provocative intravenous 
injection of the same filtrate 24 hours later.  The same phenomenon of inhibition 
was observed independently by the author of this paper in his experiments with 
B. coli culture filtrates (2). 
The present paper embodies a series of experiments concerning the 
inhibition of the Shwartzman phenomenon by means of active bac- 
terial filtrates. 
Material and Methods 
Typhoid and meningococcus "agar washings" filtrates used were prepared and 
titrated according to the methods described by Shwartzman. 
B. typhosus "agar washings" filtrates (3) were prepared as follows: Kolle flasks 
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containing plain veal infusion agar of pH 7.4 were seeded each with 3-4 cc. of 20 
hour old plain broth culture of B. typkosus (strain T L) diluted  1:4 with 0.9per cent 
NaCl solution.  The dilution  was made immediately  before use.  After 20 to 22 
hours of incubation the growth of each flask was washed off with 2-4 cc. of 0.9 
per cent NaC1 solution containing  0.4 per cent phenol.  The washings were then 
pooled,  centrifuged  within  the following 1 to 2 hours and the clear supematant 
fluid filtered through Berkefeld V candles shortly after centrifuging. 
The  method  of  preparation  of  meningococcus "agar washings"  filtrates  (4) 
differed from the above in the following: The inoculuro was prepared by inocula- 
tion of meningoeoecus  into 1 per cent rabbit blood  broth of pH 7.2 -  7.4.  The 
supernatant broth culture,  after 20 to 22 hours of incubation,  free of red blood 
ceils was used for inoculation of the Kolle flasks.  The Kolle flasks contained  0.7 
per cent glucose veal infusion agar. 
The quantitative measurement  of the reacting factors  (5)  was carried  out as 
follows: The rabbits  used  for titrations  were each  injected  intmdermally with 
0.25 cc. of the undiluted filtrate or filtrate  diluted 1:2 and divided into groups of 
three.  24 hours later a single intravenous injection of the filtrate diluted  in 0.85 
per cent NaC1 solution  was given to each rabbit.  The dose was 1 cc. per kilo of 
body weight.  Each group of rabbits received intravenously  a different dilution of 
the filtrate.  The local  reactions  were read 4 to 5 hours  after the intravenous 
injections.  The titrations were carried until the lowest dilution  was found which 
gave no reaction  in the four rabbits tested,  as well as the highest  dilution which 
gave reactions in one or more rabbits of the group.  The minimal dose of reacting 
factors was then considered as lying between these two figures.  If a given filtrate 
was employed for any length of time, repeated  control titrations were done.  In 
these control tests, the dilutions employed were both the highest dilution capable of 
eliciting reactions and the lowest dilution giving no reactions. 
EXPEI{r~NTAL 
1.  Titration  of Skin-Preparatory  Factors against 25  Reacting Units.--Prelim- 
inary experiments  suggested  that it  was  necessary  to employ a  minimal  skin- 
preparatory dose for the demonstration of inhibition  of the Shwartzman phenome- 
non.  Meningococcns  Group III "agar  washings"  filtrate  (T.1968) containing 
4,000 reacting units was used.  The skin  of rabbits was prepared with various 
dilutions of the filtrate.  For the provocative injection 25 reacting units were used 
in all the groups.  The results are recorded in Series 1 of Table I. 
As is seen from experiments of  Series 1 of Table I, severe reactions 
were obtained in skin sites of 80 per cent of rabbits prepared with 0.25 
co. of filtrate T.  1968 diluted  1:25 and  24 hours later injected intra- 
venously with 25 reacting units  (i.e.,  dilution  1:100 per kilo of body 
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2.  Inhibition  Tests.--Different  dilutions of the meningococcus filtrate (T.1968) 
were prepared.  1 cc. per kilo of body weight of each dilution was injected intra- 
venously into rabbits.  Immediately afterwards a  preparatory injection of 0.25 
cc. of the filtrate diluted 1:25 was made into the skin of the abdominal wall.  20 
TABLE  I 
First intravenous 
injection 
Dilution 
Mg. 44B. T.1968 
1:160 
1:400 
1:1,000 
1:4,000 
Mg. 44B. T.1968 
1:160 
Mg. 44B. T.1968 
1:160 
cc 
Intradermallnj~tion 
Dilution 
Mg. 44B.*T.1968 
1:25 
1:50 
1:75 
Mg. 44B. T.1968 
1:25 
~c 
Mg. 44B. T.1968 
1:25 
gc 
cg 
Mg. 44B. T.1968 
1:10 
1:2 
Mg. 44B. T.1968 
1:25 
~c 
Second intravenous 
injection 
Dilution 
Mg. 44B. T.1968 
1:160 
cg 
Mg. 44B. T.1968 
1:400 
1:1,000 
1:4,000 
Mg. 44B. T.1968 
1 : 160 
gc 
Mg. 44B. T.1968 
1:160 
Mg. 44B. T.1968 
1:80 
1:40 
~  Reaction., 
20  1  16  0  0  0  3 
50  00113 
30  00003 
50  10103 
50  00005 
51  00004 
18  6  1  0  1  010 
100  10009 
51  11002 
50  21002 
103  40003 
104  30003 
62  20002 
42  110001 
In this and the following tables, all intravenous injections were given in a dose 
of 1 cc. per kilo of body weight; all intradermal injections were given in a dose of 
0.25 cc. 
The intensity of hemorrhagic and necrotic lesions noted as 1 +, 2 +, 3 +  and 4 +. 
* Abbreviation Mg. 44B. designates "agar  washings" filtrates of  meningococ- 
cus, Group III cultures. 
to 24 hours after the intradermal injection, 1 cc. per kilo of body weight of the 
filtrate diluted  1:160 (i.e.,  25  reacting units)  was injected intravenously.  The 
readings of the skin reactions were made 4 to 5 hours after the last injection.  The 
results are recorded in Series 3 of Table I. 62  INHIBITION OF SHWARTZMAN  PHENOMENON 
It became obvious from  these  experiments  that  the  Shwartzman 
phenomenon  to  meningococcus  filtrate  could  be  almost  completely 
inhibited  by an  intravenous  injection  of the  filtrate  simultaneously 
with the skin-preparatory  injection of the same filtrate  in  a  dose of 
0.23 cc. of dilution 1: 25.  The effective inhibitory doses were dilutions 
ranging  from  1-:160  to  1:400.  The  inhibitory  effect of  a  dilution 
1:1,000 was doubtful and higher dilutions remained without effect. 
S~milar experiments were carded out with increasing concentrations of the skin- 
preparatory  dose and constant doses of the inhibitory and provocative injections. 
The results are recorded in Series 4 of Table I. 
As is seen  from  these  experiments, an  intravenous  injection of fil- 
trate  T.  1968 given simultaneously with  the skin-preparatory  injec- 
tion of the same filtrate in dilutions lower than  1:25 failed to inhibit 
the Shwartzman phenomenon. 
In experiments of Series 5 of Table I, constant amounts were used for the inhibi- 
tory intravenous  injections (i.e.,  dilution 1 : 160)  and  preparatory  intradermal 
injections (i.e.,  dilution  1:25).  Rabbits thus  treated  were tested with various 
provocative doses.  If the results of Series 5 are compared with those of Series 3, 
it is obvious that no inhibition of the Shwartzman phenomenon took place if di- 
lutions lower than 1 : 160 were used for the provocative injections. 
From the results thus far recorded, it becomes clear that  an intra- 
venous injection accompanying the intradermal  preparatory injection 
may inhibit  the Shwartzman  phenomenon within the limits of certain 
quantitative relationships. 
The  experiments  recorded  below  were  planned  to  determine  the 
optimum time relationships  between the inhibitory,  preparatory and 
provocative injections. 
In the experiments of Series 1 of Table II, the intervals of time between  the 
inhibitory intravenous injections and the preparatory  intradermal injections were 
varied.  The latter injections were given 1, 3 and 4 hours  after  the  inhibitory 
intravenous  injections.  The provocative injections were given 20 to 24  hours 
after the intradermal  preparatory  injections. 
As is  seen from  Series  1  of Table  II,  an intravenous  injection  of 
meningococcus filtrate T. 1968 diluted 1: 160, given 1 hour prior to the 
preparatory  intradermal  injection,  was  capable  of  inhibiting  the 
Shwartzman phenomenon almost as effectively as an inhibitory injec- TOMIO OGATA  63 
tlon given simultaneously with the preparatory injection.  An inhibi- 
tory intravenous injection given 4 hours before the preparatory intra- 
dermal injection remained without effect.  A  3 hour interval between 
the inhibitory and preparatory injections gave only irregular results. 
It  can  be  stated,  then,  that  inhibitory  effect of  an  intravenous 
injection of a bacterial filtrate is of short duration. 
In experiments of Series 2 of Table II, the intradermal preparatory injections 
were given prior to the inhibitory intravenous injections.  The number of animals 
TABLE II 
d  First  intravenous 
in~ection 
Dilution 
Mg. 44B. T.1968 
1:150 
c~ 
Intradermally 
0.25 cc. one 
Intradermal  injection 
Dilution 
Mg. 44B. T.1968 
1:25 
¢c 
First  i.v.  injection 
Second intravenous  d  a 
injection  ~.~ 
Dilution  ~ 
t4B.•  kilo  Icc.i'v'~i  injec-j 
Mg. 44B. T.1968 
Second i.v. 
area 
Mg. 44B. T.1968 
1:25 
¢c 
1 cc. per kilo 
Mg. 44B. T.1968 
1:160 
¢¢ 
tion 1 cc. per 
Mg. 44B. T.1968 
Already positive before the second intravenous injection. 
Reactions 
employed in these experiments was  rather smaU.  The facts suggest, however, 
that  an  intravenous injection given 1  hour  after the  preparatory intradermal 
injection  may  inhibit  the  Shwartzman  phenomenon.  Inhibitory  intravenous 
injections given at longer periods of time, i.e.,  2 and 4 hours after theintradermal 
injection, apparently produced no effect.  In some rabbits the state of reactivity 
was  already induced several hours after the  preparatory injections.  For this 
reason, the intravenous injections intended to inhibit the Shwartzman phenomenon 
served as provocative injections and elicited  reactions in  prepared sites.  The 
fact  introduced  dit~culties~ in  the  interpretation  of the results of  experiments 
with  the  4  hour  interval  of  time  between  skin-preparatory and  intravenous 
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TABLE  III 
1 
First intravenous 
injection 
Dilution 
B.TyTr.* T.1976 
1:16 
B.TyT  L T.1986 
1:28 
1:56 
1:100 
1:400 
B.  coli  filtrate 
T.1964, 1:3 
1:15 
1:30 
1 : 100 
1:400 
Streptococcus  hemo- 
lyticus  filtrate 
T.1983, undiluted 
Streptococcus  hemo- 
lyticus  filtrate 
T.1989, undiluted 
Plain broth 1:2 sa- 
line 
Horse serum (I-L693) 
undiluted 
Intradermal  injection 
Dilution 
Mg. 44B. T.1968 
1:25 
Mg, 44B. T.1968 
1:25 
Mg. 44B. T.1968 
1:25 
tc 
gc 
Mg. 44B. T.1968 
1:25 
Mg. 44B. T.1968 
1:25 
Mg. 44B. T.1968 
1:25 
Second intravenous 
in]ectlon 
Dilution 
Mg. 44B. T.1968 
1:160 
B.TyT~ T.1976 
1:16 
B.TyT~ T. 1986 
1:28 
1:56 
1:100 
1: 800 
Mg. 44B. T.1968 
1:160 
¢c 
tl 
B.  coli  filtrate 
T.1964, 1:3 
1:15 
1:30 
Mg. 44B. T.1968 
1:160 
Mg. 44B. T.1968 
I:160 
Reactions 
10502102 
52110002 
11430004 
150~00013 
51  0101 
i 
5C40001 
5020102 
50[30002 
51i40000 
5GII003 
14720005 
10  ~120005 
5  i0004 
I03140003 
50i40001 
50132000 
5020102 
5000005 
I 
502110!1 
!'3i0  1  1  0  011 
! 
! 
103410'0,2 
s13oooi 
* Abbreviation B.TyTL  designates "agar  washings" filtrates of B.  typkosus, 
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As is seen from the results of the above group of experiments, the 
inhibitory effect of an additional injection may not last longer than 2 
hours.  It  seems to  be  definitely effective, however,  if  it  is  given 
before the skin preparation takes place. 
It is well known that the Shwartzman phenomenon can be elicited 
by combined injections of heterologous bacterial filtrates.  It seemed 
of interest to determine whether there existed any specificity in the 
inhibition described. 
In the experiments recorded in Series 1, 3, 5 and 6 of Table III, the Shwartzman 
phenomenon was elicited by means of meningococcus "agar washings" filtrates 
T.1968 (i.e., intradermaUy, dilution 1:25 and  intravenously, dilution  1:160). 
The inhibition was attempted by means of additional intravenous injections of B. 
typhosus T L "agar washings" filtrate (T.1976 and T.1986, Series 1, Table III); B. 
coli "agar washings" filtrates (Series 3, Table  III);  Streptococcus hernolyticus fil- 
trate T.1983 (Series 5, Table nI); plain broth, normal horse serum and physi- 
ologic saline solution (Series 6, Table III). 
As is seen from the experiments of Table III, no specificity of the 
inhibition reaction described could be observed.  B. typhosus  culture 
filtrate in  dilution  1:100  was able to inhibit  almost completely the 
Shwartzman phenomenon to meningococcus filtrate.  Similarly, B. coli 
filtrate was effective in dilutions 1: 30 and 1 : 100.  As is also seen from 
Table  nI,  additional  intravenous  injections  of  Streptococcus  hemo- 
lyticus filtrate and of non-bacterial substances (i.e., plain broth, normal 
horse  serum  and  physiologic  saline  solution)  failed  to  inhibit  the 
Shwartzman phenomenon.  In preliminary experiments not described 
in this paper, these agents were also  shown to be lacking in reacting 
potency. 
The facts suggest that the inhibitory effect of an additional intra- 
venous injection can be obtained only with substances potent in the 
elicitation of the  Shwartzman phenomenon itself. 
COMME.NT 
It appears from the above experiments that the Shwartzman phe- 
nomenon can be inhibited if an additional  intravenous injection of a 
potent bacterial filtrate is given within a  certain period of time prior 
to or following the skin-preparatory injection.  The inhibitory effect 
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certain quantitative relationships.  Thus, if the skin is prepared with 
a  large  amount of  filtrate,  the  inhibition is  absent  or  incomplete. 
Similarly, if a large amount of filtrate is used for the provocative in- 
jection, there occurs no inhibition.  It is also obvious that the inhibi- 
tion described is of a  transitory nature.  The additional intravenous 
injection given several hours before or after the skin-preparation has 
no inhibitory effect.  The inhibition can be obtained only with filtrates 
capable of eliciting the Shwartzman phenomenon.  Bacterial filtrates 
of low reacting potency (Streptococcus  hemolyticus filtrate employed in 
these experiments) as well as non-bacterial substances (i.e., 0.85  per 
cent NaC1 solution, plain broth and normal horse serum) produce no 
inhibition. 
The mechanism of the inhibition remains unknown.  Several ex- 
planations suggest themselves.  Duran-Reynals  (6)  reported on the 
presence of spreading factors in bacterial filtrates capable of enhancing 
tissue permeability.  It is possible that an intravenous injection of a 
bacterial filtrate accompanying the skin preparation may enhance the 
rate of diffusion of the material injected locally through increase in the 
capillary or lymphatic permeability.  The preparatory factors thus 
diluted  might  not  bring  about  a  state  of  reactivity.  Gross  and 
histological  examination  of  the  tissue  where  reactions  had  been 
inhibited  did  not  disclose,  however,  any  spreading  phenomenon. 
Further studies are under way. 
Recently,  experiments  on  generalized  Shwartzman  phenomenon 
have been described by  Gratia  and Linz  (7),  Apitz  (8)  and  Gerber 
(9).  The  phenomenon was  elicited  by  means  of  two  intravenous 
injections, 24  hours apart.  While the work reported in this paper 
was in progress, Apitz suggested the following explanation for inhibi- 
tion of the local Shwartzman phenomenon: 
The inhibitory intravenous injection may elicit a state of reactivity 
in the internal organs.  Following the second intravenous injection 
reactions would occur in organs  thus prepared.  If a  small dose is 
used  for  the  provocative  injection,  the  amount  injected  may  be 
consumed in the production of lesions in the internal organs and thus 
an insufficient amount would remain for the elicitation of the reaction 
in the skin. 
To determine whether this assumption could be used for the explana- TOMIO  OGATA  67 
tion of the inhibition here described,  the internal organs of a  large 
series of rabbits were examined in the gross and microscopically.  Rab- 
bits showing complete inhibition of the local Shwartzman phenomenon 
showed only rarely lesions in the internal organs, possibly because the 
doses employed were too small for the elicitation of the generalized 
Shwartzman phenomenon. 
The  inhibition  of the  Shwartzman phenomenon cannot  be  inter- 
preted as an anaphylactic desensitization for the following reasons. 
1.  Inhibition takes place  if the additional intravenous injection is given simul- 
taneously or shortly before and after the preparatory injection.  Obviously  an 
anaphylactic desensitization cannot  be  expected to  occur  before sensitization 
is induced. 
2.  There is no specificity  of inhibition. 
A great deal of experimental evidence in the literature supports the 
possibility that processes exemplified by the Shwartzman phenomenon 
take place in induced and spontaneous bacterial and virus infections. 
The factors responsible for the Shwartzman phenomenon and deriving 
from infected loci may induce a state of reactivity in tissues and organs 
removed from the sites of initial infection.  When the state of reac- 
tivity establishes itself, discharge of the same factors into the blood 
stream would then elicit severe hemorrhagic lesions in these reactive 
sites.  The  mechanism might  then  be  responsible  for  pathological 
lesions  scattered through the body,  and  the inhibitory reaction de- 
scribed in this paper might prevent their occurrence. 
SUMMARY 
The Shwartzman phenomenon can be inhibited by an intravenous 
injection of a  potent  bacterial filtrate  within a  few hours before or 
after the preparatory intradermal injection. 
The inhibitory effect is produced non-specifically by filtrates potent 
in the elicitation of the Shwartzman phenomenon, and it is of a  transi- 
tory nature. 
The relation of the observation described to anaphylactic desensi- 
tization and to its clinical significance is discussed in this paper. 
The author wishes to express his gratitude to Dr. Gregory Shwartz- 
man for the opportunity to carry out most of these experiments in his 
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